A diseased heart is less able to cope with changes in metabolic demand, preload and afterload, which raises the risk of anaesthesia. This webinar starts with the links between blood pressure, cardiac output, stroke volume and heart rate, then looks at the usual “heart safe” protocol: a conservative fluid rate, drugs with minimal cardiac effects, and the lowest effective concentration of isoflurane or sevoflurane. It compares the common heart diseases of dogs (myxomatous mitral valve disease and dilated cardiomyopathy) with hypertrophic cardiomyopathy in cats.
The second half explains why a heart safe protocol isn’t always enough, covering heart rate control, ejection fraction, positive inotropes and why they help less in cats with HCM. It finishes with pain management, including the cardiac effects of pain, where ketamine and dexmedetomidine fit in an analgesic plan, and a dental case to think through for a dog and a cat.
Presented by Travis Bruns as part of the ACVN 2025 webinar series.
Includes the full recording (1 hour 4 minutes), the presentation slides as a PDF, and a quiz. Pass the quiz to receive a certificate worth 1 AVNAT point.

